Myeloid drugs rarely prove immune conversion in solid tumors
A 2026 narrative review finds that most myeloid-directed cancer programs show target activity without proving immune conversion and proposes a ...
A 2026 narrative review finds that most myeloid-directed cancer programs show target activity without proving immune conversion and proposes a ...
A new study identifies miR-145 as a driver and biomarker of the fibrotic tumor microenvironment, linking NOTCH signaling, promoter hypomethylation, ...
A macrophage enzyme called transketolase emerges as a metabolic checkpoint controlling blood vessel regeneration in diabetic wounds, and a nanozyme ...
Deep in the wheat blocks of high-temperature Daqu, the fermentation starter that anchors the production of premium Moutai-flavor Baijiu, temperatures ...
A dual proteomics and glycoproteomics study of Nannochloropsis oceanica maps 5,136 proteins and 459 N-glycosylation sites, showing that sugar modifications ...
A new review highlights how induced pluripotent stem cells are being engineered into immune cells, cancer vaccines, and tumor models ...
Researchers discovered that the RNA-modifying enzyme PUS7 pseudouridylates the noncoding RNA 7SK to recruit the BAF chromatin-remodeling complex, enabling a ...
New research in C. elegans reveals that the gene lin-15A enables natural cell identity conversion by weakening chromatin-based safeguards rather ...
Researchers at the Coriell Institute have created a publicly available iPSC resource with HiFi long-read whole-genome sequencing, pharmacogenomic and HLA ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.